» Articles » PMID: 26496700

Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma

Overview
Journal PLoS One
Date 2015 Oct 27
PMID 26496700
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Rhabdomyosarcoma (RMS), a cancer characterized by features of skeletal muscle histogenesis, is the most common soft tissue sarcoma of childhood and adolescence. Survival for high-risk groups is less than 30% at 5 years. RMS also occurs during adulthood, with a lower incidence but higher mortality. Recently, mutational profiling has revealed a correlation between activating Ras mutations in the embryonal (eRMS) and pleomorphic (pRMS) histologic variants of RMS, and a poorer outcome for those patients. Independently, the YAP transcriptional coactivator, an oncoprotein kept in check by the Hippo tumor suppressor pathway, is upregulated in eRMS. Here we show that YAP promotes cell proliferation and antagonizes apoptosis and myogenic differentiation of human RMS cells bearing oncogenic Ras mutations in cell culture studies in vitro and in murine xenografts in vivo. Pharmacologic inhibition of YAP by the benzoporphyrin derivative verteporfin decreased cell proliferation and tumor growth in vivo. To interrogate the temporal contribution of YAP in eRMS tumorigenesis, we used a primary human cell-based genetic model of Ras-driven RMS. Constitutively active YAP functioned as an early genetic lesion, permitting bypass of senescence and priming myoblasts to tolerate subsequent expression of hTERT and oncogenic Ras, which were necessary and sufficient to generate murine xenograft tumors mimicking RMS in vivo. This work provides evidence for cooperation between YAP and oncogenic Ras in RMS tumorigenesis, laying the foundation for preclinical co-targeting of these pathways.

Citing Articles

Myogenesis gone awry: the role of developmental pathways in rhabdomyosarcoma.

Gustafson A, Durbin A, Artinger K, Ford H Front Cell Dev Biol. 2025; 12:1521523.

PMID: 39902277 PMC: 11788348. DOI: 10.3389/fcell.2024.1521523.


Emerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders.

Han J, Zhang J, Zhang X, Luo W, Liu L, Zhu Y Stem Cell Res Ther. 2024; 15(1):386.

PMID: 39468616 PMC: 11520482. DOI: 10.1186/s13287-024-04011-9.


Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational Research.

Giusti V, Miserocchi G, Sbanchi G, Pannella M, Hattinger C, Cesari M Biomedicines. 2024; 12(8).

PMID: 39200384 PMC: 11352184. DOI: 10.3390/biomedicines12081921.


Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.

Novoplansky O, Shnerb A, Marripati D, Jagadeeshan S, Shareb R, Conde-Lopez C Mol Oncol. 2023; 17(12):2618-2636.

PMID: 37501404 PMC: 10701778. DOI: 10.1002/1878-0261.13500.


Identification and targeting of a HES1-YAP1-CDKN1C functional interaction in fusion-negative rhabdomyosarcoma.

Kovach A, Oristian K, Kirsch D, Bentley R, Cheng C, Chen X Mol Oncol. 2022; 16(20):3587-3605.

PMID: 36037042 PMC: 9580881. DOI: 10.1002/1878-0261.13304.


References
1.
Zhou D, Conrad C, Xia F, Park J, Payer B, Yin Y . Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell. 2009; 16(5):425-38. PMC: 3023165. DOI: 10.1016/j.ccr.2009.09.026. View

2.
Ognjanovic S, Linabery A, Charbonneau B, Ross J . Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer. 2009; 115(18):4218-26. PMC: 2953716. DOI: 10.1002/cncr.24465. View

3.
Hettmer S, Liu J, Miller C, Lindsay M, Sparks C, Guertin D . Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells. Proc Natl Acad Sci U S A. 2011; 108(50):20002-7. PMC: 3250188. DOI: 10.1073/pnas.1111733108. View

4.
Kipling D . Telomere structure and telomerase expression during mouse development and tumorigenesis. Eur J Cancer. 1997; 33(5):792-800. DOI: 10.1016/S0959-8049(97)00060-9. View

5.
Stratton M, Fisher C, Gusterson B, Cooper C . Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res. 1989; 49(22):6324-7. View